Scarica l'app Stockscreener
0.00
100.00%
-29.08
Mersana Therapeutics Inc Azioni (MRSN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
78.14%
2.754
|
12.60 | 2.293 | 9.245 |
Operating Expenses
|
10.54%
27.27
|
24.67 | 27.75 | 30.25 |
| Benefits Costs and Expenses |
13.50%
26.88
|
23.68 | - | 28.55 |
| Costs And Expenses |
13.50%
26.88
|
23.68 | 27.75 | 28.55 |
| Operating Income/Loss |
103.10%
-24.51
|
-12.07 | -25.45 | -21.00 |
| Nonoperating Income/Loss |
60.55%
0.389
|
0.986 | 1.187 | 1.695 |
| Income/Loss From Continuing Operations Before Tax |
117.66%
-24.12
|
-11.08 | -24.27 | -19.31 |
| Income/Loss From Continuing Operations After Tax |
109.75%
-24.12
|
-11.50 | -24.27 | -19.31 |
|
Net Income/Loss
|
109.75%
-24.12
|
-11.50 | -24.27 | -19.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - |
| Basic Average Shares |
1.42%
124.47
|
122.72 | 122.44 | 121.42 |
| Diluted Average Shares |
1.42%
124.47
|
122.72 | 122.44 | 121.42 |
| Basic Earnings Per Share |
111.11%
-0.19
|
-0.09 | -0.20 | -0.16 |
| Diluted Earnings Per Share |
111.11%
-0.19
|
-0.09 | -0.20 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):